Prescribing, Policies and Pathways
or
Medicine / Guideline | Indication | RAG rating | Document type | Place |
---|---|---|---|---|
Access To Mental Health Services Guidance | n/a | Decision document | East and North Hertfordshire, South and West Hertfordshire, West Essex | |
Agomelatine | Major depressive episodes | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Antipsychotic depot injections | Schizophrenia | Red | n/a | Hertfordshire and West Essex ICB |
Aripiprazole | Moderate to severe manic episodes in adolescents with bipolar I disorder | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol children and young people (methylphenidate, lisdexamfetamine, dexamfetamine, atomoxetine or guanfacine) | Amber protocol | Shared care protocol | West Essex |
Behavioural and Psychological Symptoms of Dementia (BPSD) | Dementia | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Buprenorphine oral lyophilisate | Opioid drug dependence | Double Red | Decision document | Hertfordshire and West Essex ICB |
Clonidine | Attention deficit hyperactivity disorder (ADHD) | Red | Decision document | Hertfordshire and West Essex ICB |
Clozapine | Schizophrenia | Red | n/a | Hertfordshire and West Essex ICB |
CYP Eating Disorders and Emotional Distress | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Dementia | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Depression | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Dosulepin | Depression | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Dosulepin Patient Information Leaflet | Depression | n/a | Patient information | Hertfordshire and West Essex ICB |
Esketamine | Depression - major | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | West Essex |
Lithium | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
Lithium Primary Care action plan | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Loxapine | Acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Lurasidone | Schizophrenia | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
Pathological Demand Avoidance | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Quetiapine | Schizophrenia and bipolar disorder | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Sodium valproate | All indications | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
Transcranial Magnetic Stimulation (TMS and rTMS) | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Trimipramine | Depression | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Trimipramine | Depression | n/a | Patient information | Hertfordshire and West Essex ICB |
Venlafaxine | Depression, anxiety and panic disorders | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Vortioxetine | Major depressive episodes | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |